Financial IP Exchange To Launch First Contract Offering In June 29/05/2013 by Intellectual Property Watch Leave a Comment The Intellectual Property Exchange International Inc. (IPXI), the world’s first financial exchange that facilitates non-exclusive licensing and trading of IP rights, will start offering a licence contract in June.
Civil Society Observer At UPOV Gets A Public Face 29/05/2013 by Intellectual Property Watch Leave a Comment The Association for Plant Breeding for the Benefit of Society (APBREBES) announced that its website is now online and its first newsletter has been issued.
Despite Economic Growth, Africa Struggles To Meet All MDGs 28/05/2013 by Intellectual Property Watch Leave a Comment Despite increased economic growth over the past decade, Africa will not reach some of the Millennium Development Goal (MDG) targets set forth in 2000 by the United Nations, including halving poverty by 2015, according to a UN report released yesterday.
Publishers Challenge Quality Of Open Educational Resources 28/05/2013 by Intellectual Property Watch 5 Comments The International Publishers Association (IPA) has published a paper that raises questions about the quality, sustainability, and public funding of Open Educational Resources (OER).
World Health Assembly: IP Considerations Play Key Role In Final Outcomes 28/05/2013 by Rachel Marusak Hermann and Brittany Ngo for Intellectual Property Watch 1 Comment Wrapping up one day early, the 66th World Health Assembly adopted a range of public health resolutions and decisions, some with key intellectual property implications, including a decision to convene a technical meeting on new public health R&D projects, a compromise on advancing the poor quality medicines mechanism, and resolutions on both neglected tropical diseases and noncommunicable diseases. Importantly, the novel coronavirus situation drew attention to WHO’s progress in pandemic influenza preparedness.
Focus On Quality For Patients Saves Billions Of Dollars 27/05/2013 by Intellectual Property Watch Leave a Comment Daniela Bagozzi writes: Ten years of efforts in treatment for priority diseases has yielded impressive results both in terms of lives and dollars saved. To maintain progress in a volatile and financially tight environment countries and the international community will need to increase pressure on quality and healthy generic competition.
At WTO, LDC Fight For Extension Of TRIPS Transition Continues 24/05/2013 by William New, Intellectual Property Watch 3 Comments Over the past week or so, least-developed country (LDC) members of the World Trade Organization have held their own in a closed room with the world’s biggest economies as they worked out details of a request by the LDCs to extend the deadline by which they must enforce WTO intellectual property rules.
WHO Should Have The Evidence? Ben Goldacre Refutes WHO Director’s Claim 24/05/2013 by Intellectual Property Watch 2 Comments “Bad Science” adversary and journalist, Dr Ben Goldacre, this week challenged WHO Director of Ethics and Social Determinants of Health, Dr Rüdiger Krech, on his understanding of published evidence.
World Health Assembly: Groups Seek To Return Focus To ‘Broken’ Medical R&D System 24/05/2013 by Brittany Ngo for Intellectual Property Watch and William New Leave a Comment The issue of access to medicines is on the agenda at this week’s World Health Assembly (WHA) and public health advocates are seeking greater clarity and detail about the latest member state effort to address failings in the global system of research and development for medical products.
EPO Still Granting Patents On Conventional Vegetables; ‘Just Following Rules’ 24/05/2013 by Catherine Saez, Intellectual Property Watch 4 Comments The European Patent Office is continuing to grant patents on conventional plants despite demands from the European Parliament and the German Parliament that the patent office refrain from granting such patents, the coalition of non-governmental organisations called “No patents on seeds” said in a release.